HRS/EHRA/APHRS Expert Consensus Diagnostic Criteria for Brugada Syndrome (2013)

  1. Brugada syndrome is diagnosed in patients with ST-segment elevation with type 1 morphology > 2 mm in > 1 lead among the right precordial leads V1, V2, positioned in the 2nd, 3rd, or 4th intercostal space occurring either spontaneously or after provocative drug test with intravenous administration of Class I antiarrhythmic drugs.
  2. Brugada syndrome is diagnosed in patients with type 2 or type 3 ST-segment elevation with > 1 lead among the right precordial leads V1, V2, positioned in the 2nd, 3rd, or 4th intercostal space occurring when a provocative drug test with intravenous administration of Class I antiarrhythmic drugs induces a type 1 ECG morphology.

Reference

Priori SG, Wilde AA, Horie M, et al. HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes: Document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm. 2013;10(12):1932-1963. https://doi.org/10.1016/j.hrthm.2013.05.014